Quantitative Analysis of Angiogenesis Inhibition by Cleaved High Molecular Weight Kininogen Using VESGEN
Angiogenesis requires specific molecular regulation of complex vascular branching morphology. The cleaved form of high molecular weight kininogen (HKa) has been shown to cause apoptosis of proliferating endothelial cells, and inhibit angiogenesis in vivo. However, critical morphological effects of H...
Saved in:
Published in | Blood Vol. 110; no. 11; p. 3907 |
---|---|
Main Authors | , , , , , , , |
Format | Journal Article |
Language | English |
Published |
Elsevier Inc
16.11.2007
|
Online Access | Get full text |
Cover
Loading…
Abstract | Angiogenesis requires specific molecular regulation of complex vascular branching morphology. The cleaved form of high molecular weight kininogen (HKa) has been shown to cause apoptosis of proliferating endothelial cells, and inhibit angiogenesis in vivo. However, critical morphological effects of HKa on the complex branching morphology of angiogenic vascular trees have not been defined. We used the quail chorioallantoic membrane (CAM) angiogenesis assay, in which angiogenesis agonists or antagonists cause uniform perturbation of angiogenesis throughout the entire vascular tree, to assess the effects of HKa on branching morphology. HKa (1.56 to 50 micrograms) was applied uniformly to the CAM, and its effect on angiogenesis determined after 24 hours of incubation. VESGEN vascular analysis software, currently under development at NASA Glenn Research Center, was used to quantify major vessel parameters in low-magnification images of vascular trees automatically extracted by VESGEN. Results derived from qualitative observation and initial quantification of two experiments demonstrates that HKa significantly inhibits vascular growth. Vessel length density (Lv) and branch point density (Br) in CAM specimens treated with 25 micrograms of HKa decreased by 23% and 31% respectively (24 ± 1 cm/cm2 and 441 ± 43 /cm2, compared to 31 ± 0 cm/cm2 and 677 ± 51 /cm2 in vehicle-treated controls; mean +/− S.E. for n = 3). The fractal dimension (Df) of skeletonized vascular images is a highly sensitive indicator of vessel density that ranges from 1.35 for strong angiogenesis inhibition, to 1.40 and 1.48 for controls and strong angiogenesis stimulation, respectively. Df decreased to 1.35 ± 0.01 in the HKa-treated specimens, relative to 1.39 ± 0.00 in controls. However, thickening of large vessels in response to HKa resulted in a virtually equivalent vessel area density (Av) of 0.167 ± 0.012 cm2/cm2, relative to 0.174 ± 0.015 cm2/cm2 in controls. Further studies of the site-specific effects of HKa on branching morphology within the vascular tree are in progress. These results demonstrate that the antiangiogenic effects of HKa result in a unique antiangiogenic 'fingerprint' vascular morphology in comparison to other angiogenesis inhibitors that include transforming growth factor-β1 and angiostatin. |
---|---|
AbstractList | Angiogenesis requires specific molecular regulation of complex vascular branching morphology. The cleaved form of high molecular weight kininogen (HKa) has been shown to cause apoptosis of proliferating endothelial cells, and inhibit angiogenesis in vivo. However, critical morphological effects of HKa on the complex branching morphology of angiogenic vascular trees have not been defined. We used the quail chorioallantoic membrane (CAM) angiogenesis assay, in which angiogenesis agonists or antagonists cause uniform perturbation of angiogenesis throughout the entire vascular tree, to assess the effects of HKa on branching morphology. HKa (1.56 to 50 micrograms) was applied uniformly to the CAM, and its effect on angiogenesis determined after 24 hours of incubation. VESGEN vascular analysis software, currently under development at NASA Glenn Research Center, was used to quantify major vessel parameters in low-magnification images of vascular trees automatically extracted by VESGEN. Results derived from qualitative observation and initial quantification of two experiments demonstrates that HKa significantly inhibits vascular growth. Vessel length density (Lv) and branch point density (Br) in CAM specimens treated with 25 micrograms of HKa decreased by 23% and 31% respectively (24 ± 1 cm/cm2 and 441 ± 43 /cm2, compared to 31 ± 0 cm/cm2 and 677 ± 51 /cm2 in vehicle-treated controls; mean +/− S.E. for n = 3). The fractal dimension (Df) of skeletonized vascular images is a highly sensitive indicator of vessel density that ranges from 1.35 for strong angiogenesis inhibition, to 1.40 and 1.48 for controls and strong angiogenesis stimulation, respectively. Df decreased to 1.35 ± 0.01 in the HKa-treated specimens, relative to 1.39 ± 0.00 in controls. However, thickening of large vessels in response to HKa resulted in a virtually equivalent vessel area density (Av) of 0.167 ± 0.012 cm2/cm2, relative to 0.174 ± 0.015 cm2/cm2 in controls. Further studies of the site-specific effects of HKa on branching morphology within the vascular tree are in progress. These results demonstrate that the antiangiogenic effects of HKa result in a unique antiangiogenic 'fingerprint' vascular morphology in comparison to other angiogenesis inhibitors that include transforming growth factor-β1 and angiostatin. Abstract Angiogenesis requires specific molecular regulation of complex vascular branching morphology. The cleaved form of high molecular weight kininogen (HKa) has been shown to cause apoptosis of proliferating endothelial cells, and inhibit angiogenesis in vivo. However, critical morphological effects of HKa on the complex branching morphology of angiogenic vascular trees have not been defined. We used the quail chorioallantoic membrane (CAM) angiogenesis assay, in which angiogenesis agonists or antagonists cause uniform perturbation of angiogenesis throughout the entire vascular tree, to assess the effects of HKa on branching morphology. HKa (1.56 to 50 micrograms) was applied uniformly to the CAM, and its effect on angiogenesis determined after 24 hours of incubation. VESGEN vascular analysis software, currently under development at NASA Glenn Research Center, was used to quantify major vessel parameters in low-magnification images of vascular trees automatically extracted by VESGEN. Results derived from qualitative observation and initial quantification of two experiments demonstrates that HKa significantly inhibits vascular growth. Vessel length density (Lv) and branch point density (Br) in CAM specimens treated with 25 micrograms of HKa decreased by 23% and 31% respectively (24 ± 1 cm/cm2 and 441 ± 43 /cm2, compared to 31 ± 0 cm/cm2 and 677 ± 51 /cm2 in vehicle-treated controls; mean +/− S.E. for n = 3). The fractal dimension (Df) of skeletonized vascular images is a highly sensitive indicator of vessel density that ranges from 1.35 for strong angiogenesis inhibition, to 1.40 and 1.48 for controls and strong angiogenesis stimulation, respectively. Df decreased to 1.35 ± 0.01 in the HKa-treated specimens, relative to 1.39 ± 0.00 in controls. However, thickening of large vessels in response to HKa resulted in a virtually equivalent vessel area density (Av) of 0.167 ± 0.012 cm2/cm2, relative to 0.174 ± 0.015 cm2/cm2 in controls. Further studies of the site-specific effects of HKa on branching morphology within the vascular tree are in progress. These results demonstrate that the antiangiogenic effects of HKa result in a unique antiangiogenic ’fingerprint’ vascular morphology in comparison to other angiogenesis inhibitors that include transforming growth factor-β1 and angiostatin. |
Author | Rasin, Arkady Parsons-Wingerter, Patricia McCrae, Keith R. McKay, Terri L. Gedeon, Daniel J. Hylton, Alan G. Ribita, Daniela Zlotoff, Benjamin |
Author_xml | – sequence: 1 givenname: Daniela surname: Ribita fullname: Ribita, Daniela organization: Microgravity Science Division, John Glenn NASA Research Center, Cleveland, OH, USA – sequence: 2 givenname: Benjamin surname: Zlotoff fullname: Zlotoff, Benjamin organization: Hematology-Oncology, Case Western Reserve University School of Medicine, Cleveland, OH, USA – sequence: 3 givenname: Terri L. surname: McKay fullname: McKay, Terri L. organization: Microgravity Science Division, John Glenn NASA Research Center, Cleveland, OH, USA – sequence: 4 givenname: Daniel J. surname: Gedeon fullname: Gedeon, Daniel J. organization: Microgravity Science Division, John Glenn NASA Research Center, Cleveland, OH, USA – sequence: 5 givenname: Alan G. surname: Hylton fullname: Hylton, Alan G. organization: Microgravity Science Division, John Glenn NASA Research Center, Cleveland, OH, USA – sequence: 6 givenname: Arkady surname: Rasin fullname: Rasin, Arkady organization: Hematology-Oncology, Case Western Reserve University School of Medicine, Cleveland, OH, USA – sequence: 7 givenname: Keith R. surname: McCrae fullname: McCrae, Keith R. organization: Hematology-Oncology, Case Western Reserve University School of Medicine, Cleveland, OH, USA – sequence: 8 givenname: Patricia surname: Parsons-Wingerter fullname: Parsons-Wingerter, Patricia organization: Microgravity Science Division, John Glenn NASA Research Center, Cleveland, OH, USA |
BookMark | eNqFkN1OwkAQhTcGEwF9BvcFirvd0m0vCUEgosYoeNnszxTG1F3TLSS8vW3x3psz812ck5kzIgPnHRByz9mE8yx-0JX3drLjPU9EzmQvV2TIp3EWMRazARkyxtIoySW_IaMQvhjjiYinQ3J4OyrXYKMaPAGdOVWdAwbqy3bfo9-Dg47X7oAaG_SO6jOdV6BOYOkK9wf67Cswx0rV9BNabugTOnSdk24Duj3dLd6Xi5dbcl2qKsDd3xyT7ePiY76KNq_L9Xy2iQxnqYxKrePMCp0ZyVMGNpciLlVpuWBTkyRWa2FSnlsrc5uZXGpQMmuf0YqDYFyLMZGXXFP7EGooi58av1V9LjgrusKKvrCiK6zlouuql9Y5uzihPe-EUBfBIDgDFmswTWE9_pvxC_J9eUU |
ContentType | Journal Article |
Copyright | 2007 American Society of Hematology |
Copyright_xml | – notice: 2007 American Society of Hematology |
DBID | 6I. AAFTH AAYXX CITATION |
DOI | 10.1182/blood.V110.11.3907.3907 |
DatabaseName | ScienceDirect Open Access Titles Elsevier:ScienceDirect:Open Access CrossRef |
DatabaseTitle | CrossRef |
DatabaseTitleList | CrossRef |
DeliveryMethod | fulltext_linktorsrc |
Discipline | Medicine Chemistry Biology Anatomy & Physiology |
EISSN | 1528-0020 |
EndPage | 3907 |
ExternalDocumentID | 10_1182_blood_V110_11_3907_3907 S0006497118401607 |
GroupedDBID | --- -~X .55 1CY 23N 2WC 34G 39C 4.4 53G 5GY 5RE 5VS 6I. 6J9 9M8 AAEDW AAFTH AAXUO ABOCM ABVKL ACGFO ADBBV AENEX AFFNX AFOSN AHPSJ ALMA_UNASSIGNED_HOLDINGS BAWUL BTFSW C1A CS3 DIK DU5 E3Z EBS EJD EX3 F5P FDB FRP GS5 GX1 IH2 J5H K-O KQ8 L7B LSO MJL N4W N9A OK1 P2P R.V RHF RHI ROL SJN THE TR2 TWZ W2D W8F WH7 WOQ WOW X7M YHG YKV ZA5 ZGI 0R~ 0SF AALRI AAYXX ADVLN AITUG AKRWK AMRAJ CITATION H13 |
ID | FETCH-LOGICAL-c1067-fbb28d3b8c7160ed9732fafd1305c44dbb3c619dd79d8c97bea78014ba1e301b3 |
IEDL.DBID | ABVKL |
ISSN | 0006-4971 |
IngestDate | Fri Aug 23 02:20:10 EDT 2024 Fri Feb 23 02:43:45 EST 2024 |
IsDoiOpenAccess | true |
IsOpenAccess | true |
IsPeerReviewed | true |
IsScholarly | true |
Issue | 11 |
Language | English |
License | This article is made available under the Elsevier license. |
LinkModel | DirectLink |
MergedId | FETCHMERGED-LOGICAL-c1067-fbb28d3b8c7160ed9732fafd1305c44dbb3c619dd79d8c97bea78014ba1e301b3 |
OpenAccessLink | https://www.sciencedirect.com/science/article/pii/S0006497118401607 |
PageCount | 1 |
ParticipantIDs | crossref_primary_10_1182_blood_V110_11_3907_3907 elsevier_sciencedirect_doi_10_1182_blood_V110_11_3907_3907 |
PublicationCentury | 2000 |
PublicationDate | 2007-11-16 |
PublicationDateYYYYMMDD | 2007-11-16 |
PublicationDate_xml | – month: 11 year: 2007 text: 2007-11-16 day: 16 |
PublicationDecade | 2000 |
PublicationTitle | Blood |
PublicationYear | 2007 |
Publisher | Elsevier Inc |
Publisher_xml | – name: Elsevier Inc |
SSID | ssj0014325 |
Score | 1.9022431 |
Snippet | Angiogenesis requires specific molecular regulation of complex vascular branching morphology. The cleaved form of high molecular weight kininogen (HKa) has... Abstract Angiogenesis requires specific molecular regulation of complex vascular branching morphology. The cleaved form of high molecular weight kininogen... |
SourceID | crossref elsevier |
SourceType | Aggregation Database Publisher |
StartPage | 3907 |
Title | Quantitative Analysis of Angiogenesis Inhibition by Cleaved High Molecular Weight Kininogen Using VESGEN |
URI | https://dx.doi.org/10.1182/blood.V110.11.3907.3907 |
Volume | 110 |
hasFullText | 1 |
inHoldings | 1 |
isFullTextHit | |
isPrint | |
link | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwpV1LS8NAEB76wMdFtCo-yx7EW2yySZONt7bUV60g2uotZLObWtC0SCv03zuzTURB8OBl2Q0MhJ3lm5ndb2YATlzbVl7KA4uHqbTwhDiW4KmioelqzaVI6UW3f-dfDbyb5-ZzCTpFLgzRKnPsX2K6Qev8SyPfzcZ0PKYcXzSnYeBQjEJl0spQ5YFv8wpUW-1h7_brMcFz-bKRAQbPJJDTvNCzbhh2-NnQMWuK_wMz_G6kvhmei03YyD1G1lr-1BaUdFaD7VaG0fLbgp0yw-E0l-M1WGkXs7VO0cmtBqv9_AF9G17u53Fm8soQ5VhRkYRNUpyPxpMRIR-ur7OXsTRkLiYXrPOq4w-tGHFCWL_op8uezK0q61GLCZJkhn7Aht2Hy-7dDgwuuo-dKytvtmAlVEXOSqXkQrlSJBhB2VpRFZ80ThXauGbieUpKN8FgS6kgVCIJA6njgCrPyNjRCBLS3YVKNsn0HjA_5tLVuNtKSy9EJ0NphGMVCyfxXWWLfbCL3Y2my5oakYlFBI-MQiJSCK4j0oUZ9uG80EL043hEiPx_CR_8R_gQ1s11LjH__COozN7n-hj9kJms5-esDuXevfgEKK3aIQ |
link.rule.ids | 315,786,790,27602,27957,27958,45698 |
linkProvider | Elsevier |
linkToHtml | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwpV3dSwJBEB9MKXuJsiL73Ifo7fK-9PZ6U7E0PyAq8-24vd1ToU4JDfzvm1nvoiDooZdl92Dg2Fl-M7P7mxmAS8c0pRvbnmH7sTDwhFgGt2NJQ9VRyhY8phfd_qDWfnbvR9VRDppZLgzRKlPsX2O6Ruv0SyXdzcp8OqUcXzSnvmdRjEJl0jaggN6Az_NQqDeG3d7XY4Lr2OtGBhg8k0BK80LPuqLZ4ddDS68p_vf08LuR-mZ4bndhJ_UYWX39U3uQU0kJ9usJRstvK3bFNIdTX46XYLORzYrNrJNbCbb66QP6PkwelmGi88oQ5VhWkYTNYpyPp7MxIR-uO8lkKjSZi4kVa76q8ENJRpwQ1s_66bIXfavKutRigiSZph-wYevxrjU4gOfb1lOzbaTNFoyIqsgZsRA2l47gEUZQppJUxScOY4k2rhq5rhTCiTDYktLzJY98T6jQo8ozIrQUgoRwDiGfzBJ1BKwW2sJRuNtSCddHJ0MqhGMZciuqOdLkZTCz3Q3m65oagY5FuB1ohQSkEFwHpAs9lOEm00Lw43gEiPx_CR__R_gCiu2nfi_odQbdE9jWV7vEAqydQn7xvlRn6JMsxHl65j4BgmncJQ |
openUrl | ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Quantitative+Analysis+of+Angiogenesis+Inhibition+by+Cleaved+High+Molecular+Weight+Kininogen+Using+VESGEN&rft.jtitle=Blood&rft.au=Ribita%2C+Daniela&rft.au=Zlotoff%2C+Benjamin&rft.au=McKay%2C+Terri+L.&rft.au=Gedeon%2C+Daniel+J.&rft.date=2007-11-16&rft.issn=0006-4971&rft.eissn=1528-0020&rft.volume=110&rft.issue=11&rft.spage=3907&rft.epage=3907&rft_id=info:doi/10.1182%2Fblood.V110.11.3907.3907&rft.externalDBID=n%2Fa&rft.externalDocID=10_1182_blood_V110_11_3907_3907 |
thumbnail_l | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=0006-4971&client=summon |
thumbnail_m | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=0006-4971&client=summon |
thumbnail_s | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=0006-4971&client=summon |